Corporate Banner
Satellite Banner
Pharma Outsourcing
Scientific Community
 
Join | Sign in
Home>Products>Product News
  Service News
Debiopharm Moves Forward Three of its Oncology Clinical Programs
Thursday, May 29, 2014
Company will present the recent progresses at the 50th American Society of Clinical Oncology Annual Meeting.

Completion or Enrollment in the Phase III Confirmatory Study of KIACTA™
Thursday, May 29, 2014
KIACTA™ Phase III Confirmatory Study expected to be completed in 2016.

Sciformix to Reveal Strategic Model for Talent Acquisition at the DIA 50th Annual Meeting
Thursday, May 22, 2014
New career strategy aims to address talent acquisition and retention requirements for capacity expansion.

Aptiv Solutions Improves Accuracy of Dose Escalation Studies with Launch of ADDPLAN® DF 3.0
Friday, May 16, 2014
ADDPLAN® DF 3.0 incorporates complex statistical methodologies to prevent under and over-estimation of a therapeutic’s maximum target dose (MTD) during Phase I dose escalation trials.

Da Volterra's DAV132 Shown As Promising Candidate for Preventing Severe C. Difficile Infections
Tuesday, May 13, 2014
The CL1001 clinical trial also demonstrated the adequate targeted delivery of DAV132 to the ileum and the colon and its adsorbing effects.

Cleanroom Services Partnership Brings Synergy for Customers
Thursday, May 01, 2014
Two award-winning laboratory service providers have joined forces to create greater synergy for customers.

Quotient Clinical Extends its Translational Pharmaceutics™ Platform
Friday, April 25, 2014
Company will employ its manufacturing capabilities to supply specialist oncology centers with drug products.

New Approach to Temperature Control in Cell Therapy Clinical Trial
Wednesday, April 23, 2014
CoolCell® cell freezing device and CoolBox™ ice-free cooling workstations chosen to support handling and processing of investigational cell therapy product in landmark clinical research trial.

Critical Pharmaceuticals, The University of Nottingham and NUH Starts First Phase I Clinical Trial
Wednesday, April 16, 2014
Phase I clinical trial on a nano-enabled intranasal teriparatide for the treatment of osteoporosis.

<< 1 2 3 4 5 6 7 >>
Showing Results 21 - 30 of 307
Scientific News
NIH-funded Vaccine for West Nile Virus Enters Human Clinical Trials
Enrollment is expected to be completed by December 2015.
Gene Therapy for Cystic Fibrosis Shows Encouraging Trial Results
A therapy that replaces the faulty gene responsible for cystic fibrosis in patients' lungs has produced encouraging results in a major UK trial.
In Blinding Eye Disease, Trash-Collecting Cells Go Awry, Accelerate Damage
NIH research points to microglia as potential therapeutic target in retinitis pigmentosa.
Boys More Likely to Have Antipsychotics Prescribed, Regardless of Age
NIH-funded study is the first look at antipsychotic prescriptions patterns in the U.S.
Human Trials of Manufactured Blood Within Two Years
The first human trials of lab-produced blood to help create better-matched blood for patients with complex blood conditions has been announced by NHS Blood and Transplant.
New Medication for Alcohol Use Disorder
NIH begins clinical trial investigating a potential treatment for alcohol use disorder.
Behavior Matters: Redesigning the Clinical Trial
A recent meta-analysis of six such clinical trials shows that behavior can have a serious impact on the effectiveness of a treatment and that the currently used DBRCT procedures may not be able to assess the effects of behavior on the treatment.
New Commercial Method for Producing Medical Isotope
The effort to secure a stable, domestic source of a critical medical isotope reached an important milestone this month as scientists demonstrated the production, separation and purification of molybdenum-99 (Mo-99.
NCI-MATCH Trial will Link Targeted Cancer Drugs to Gene Abnormalities
Precision medicine trial will open to patient enrollment in July.
Linking Targeted Cancer Drugs to Gene Abnormalities
Investigators at the NIH have announced a series of clinical trials that will study drugs or drug combinations that target specific genetic mutations.
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters